Compile Data Set for Download or QSAR
Report error Found 55 Enz. Inhib. hit(s) with all data for entry = 50009553
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451124(CHEMBL2114981)
Affinity DataEC50:  28nMAssay Description:Effective concentration for agonistic activity towards delta opioid receptor was determined by [35S]GTP-gamma-S functional assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50299565((S)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl...)
Affinity DataIC50: 1.60nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451124(CHEMBL2114981)
Affinity DataIC50: 2.5nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451118(CHEMBL2114978)
Affinity DataIC50: 3.80nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084988((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 4.90nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451126(CHEMBL2114977)
Affinity DataIC50: 5.80nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084991((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 11nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451125(CHEMBL2114982)
Affinity DataIC50: 12nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451123(CHEMBL2114980)
Affinity DataIC50: 13nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084989((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 14nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084993((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 53nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451119(CHEMBL2115427)
Affinity DataIC50: 82nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451121(CHEMBL2115429)
Affinity DataIC50: 122nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084989((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 142nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084995((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 236nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451122(CHEMBL2115430)
Affinity DataIC50: 571nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451118(CHEMBL2114978)
Affinity DataIC50: 587nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451123(CHEMBL2114980)
Affinity DataIC50: 635nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50299565((S)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl...)
Affinity DataIC50: 894nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451127(CHEMBL2114986)
Affinity DataIC50: 1.08E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451126(CHEMBL2114977)
Affinity DataIC50: 1.14E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084990((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 1.16E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451127(CHEMBL2114986)
Affinity DataIC50: 1.24E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084983((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 1.52E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451124(CHEMBL2114981)
Affinity DataIC50: 1.67E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451121(CHEMBL2115429)
Affinity DataIC50: 1.94E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084995((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 2.16E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084991((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 2.28E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084993((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 2.44E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084994((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 2.54E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084988((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 2.65E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084989((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 2.73E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451125(CHEMBL2114982)
Affinity DataIC50: 2.87E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084983((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 4.64E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451123(CHEMBL2114980)
Affinity DataIC50: 5.74E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084990((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 7.22E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451118(CHEMBL2114978)
Affinity DataIC50: 7.56E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451120(CHEMBL2115434)
Affinity DataIC50: 8.13E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451122(CHEMBL2115430)
Affinity DataIC50: 8.24E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor mu 1 by displacing 125 I-FK-33824More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084991((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 9.00E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084995((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 9.29E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451125(CHEMBL2114982)
Affinity DataIC50: 9.44E+3nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084988((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451126(CHEMBL2114977)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451124(CHEMBL2114981)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084990((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451121(CHEMBL2115429)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50451120(CHEMBL2115434)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor delta 1 by displacing 125 I-deltorphin IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084994((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D MontréAl

Curated by ChEMBL
LigandPNGBDBM50084993((S)-2-[2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-p...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was evaluated for binding affinity towards Opioid receptor kappa 1 by displacing 125 I-DPDYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: